Company Overview
About Midi Health
Midi Health became digital health's first menopause-focused unicorn in February 2026, raising $100 million in Series D financing at a $1 billion valuation. The company serves 230,000+ patients across all 50 states with clinician-led care for menopause, perimenopause, and midlife women's health — a market that has been systematically underserved by mainstream healthcare despite affecting 50 million American women.
Business Model & Competitive Advantage
The $1B valuation reflects both the scale of the underserved market and Midi's clinical credibility: the platform is built around specialist clinicians rather than chatbots or wellness content, providing evidence-based hormone therapy, symptom management, and ongoing care coordination. This clinical rigor makes Midi acceptable to commercial payers and employers in a way that consumer wellness apps are not.
Competitive Landscape 2025–2026
With the 2026 round, Midi is expanding beyond menopause into cardiology, obesity, autoimmune care, and longevity — positioning itself as a full women's lifecycle platform from perimenopause through healthy aging. The hiring of Jason Wheeler (former Tesla/Google CFO) signals an IPO trajectory, making Midi one of digital health's clearest near-term public market candidates.
Open Positions
Reddit Discussions
Key Differentiators
Strong Challenger
Midi Health is an established challenger with significant market presence and competitive offerings in Digital Health.
Growth Stage
Midi Health has achieved $100M in revenue, demonstrating strong product-market fit.
Frequently Asked Questions
Not So Random Others
Oura
Oura is the maker of the Oura Ring, a premium smart ring that tracks sleep, recovery, readiness, and health metrics through continuous biometric sensing. The company raised $900 million in Series E fi
a2z Radiology AI
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disea
Honda
Honda Motor Co., Ltd. is a Japanese multinational mobility conglomerate founded in 1948 by Soichiro Honda and Takeo Fujisawa in Hamamatsu, Japan. Starting as a motorcycle manufacturer, Honda expanded
Hyundai
Hyundai Motor Company was founded in 1967 in Seoul, South Korea, by Chung Ju-yung and has grown into one of the world's largest automotive manufacturers, ranking third globally by vehicle sales. From
Benchling
Benchling is a cloud-based research and development platform purpose-built for the life sciences industry, founded in 2012 by Sajith Wickramasekara and Ashu Singhal as a Y Combinator alumnus. The comp
Tesla
Tesla is an electric vehicle and clean energy company founded in 2003 by Martin Eberhard and Marc Tarpenning in San Carlos, California, and subsequently co-founded and led by Elon Musk, who joined as
Compare Midi Health with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Midi Health? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Midi Health Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Midi Health vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →